|1.||Sciamanna, Giuseppe: 1 article (12/2011)|
|2.||Wilson, Charles J: 1 article (12/2011)|
|3.||Crest, M: 1 article (05/2004)|
|4.||Béraud, E: 1 article (05/2004)|
|5.||Devaux, J: 1 article (05/2004)|
|6.||Beeton, C: 1 article (05/2004)|
07/11/1997 - "Both the Mast Cell Degranulating (MCD) peptide and Dendrotoxin I (DTX(I)), two blockers of fast activation and slowly inactivating K+ channels, induced epileptiform seizures and brain damage after intracerebroventricular injection (200 pmol) in Sprague-Dawley rats. "
08/21/1989 - "Intracerebroventricular injection of mast-cell degranulating peptide (MCD), dendrotoxin I (DTXI) and 4-aminopyridine (4-AP), 3 blockers of a subclass of K+ channel, produces seizures and convulsions. "
01/24/1989 - "Intracerebroventricular injection into rats of mast-cell degranulating peptide (MCD), dendrotoxin I (DTXI) and 4-aminopyridine (4-AP), three blockers of a subclass of K+ channels, elicited epileptiform wave bursts and convulsions. "
02/07/1991 - "Using electroencephalographic (EEG) recordings in freely moving rats and extracellular neuronal firing-rate recordings in hippocampal slices, we examined the effects of riluzole (RP 54274), a compound with anti-glutamate properties, against the convulsive seizures and the cellular hyperexcitability produced by the mast-cell degranulating peptide (MCD), dendrotoxin I (DTXi) and 4-aminopyridine (4-AP). "
06/23/1998 - "Dendrotoxin-I, a relatively specific blocker of Kv1.1, blocks 96% of the sustained K+ current in glioma cells, causing a shift in the resting membrane potential from -40 mV to -7 mV. These data suggest that expression of Kv1.1 contributes to setting the resting membrane potential in undifferentiated glioma cells. "
|4.||Demyelinating Diseases (Demyelinating Disease)
|1.||mast cell degranulating peptide
|2.||4-Aminopyridine (4 Aminopyridine)
|4.||Glutamic Acid (Glutamate)